Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- KO.NYSE
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
Coca-Cola (KO) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
NEUTRAL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
PARTIAL SELL$88
-0.8%+1.3% incl. dividends5-Year
NEUTRAL$104
+18.3%+31.2% incl. dividendsPublished batch insight
Global Beverage Dominance Collides With Punitive Valuation Physics and Unresolved Tax Liabilities
A high consensus confirms elite operational compounding via asset-light concentrate licensing and twenty-nine percent operating margins. However, an elevated price-to-earnings multiple facing five percent sovereign yields, alongside a multi-billion-dollar federal tax appeal, caps prospective five-year equity returns near mid-single-digit annualized rates.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Machiavelli (Insider), Universal Investor (Polymath), Elon Musk (Visionary), Warren Buffett (Value Purist), Sherlock Holmes (Whistleblower), Michael Burry (Vulture), Superintelligence (Anthropologist), J.P. Morgan (Titan), Ray Dalio (Strategist). Some archetypes run in multiple modes, resulting in 14 advisors total.
Full published thesis
Executive Summary
If you invested $10,000 in Coca-Cola at the forecast anchor (2026-09-18): $13,121 in five years versus $13,892 for S&P 500 benchmark.
* Return is calculated incl. 2.1% net dividend yield for Coca-Cola.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 86.80 | -1.65% | -1.65% | Sovereign bond yields testing five percent trigger institutional multiple compression across defensive staples. Resilient holiday syrup shipments cushion baseline operating income, but negative equity risk premia drive mild initial valuation contraction. |
| Q1 2027 | 86.46 | -0.39% | -2.03% | Full-year financial reporting highlights solid organic sales growth and the customary dividend increase. Strong international price realization buffers modest winter volume softening, leaving shares consolidating in a tight trading range. |
| Q2 2027 | 86.65 | +0.22% | -1.81% | Heightened legal anticipation surrounding the Eleventh Circuit appellate tax hearings injects transient headline caution. Favorable summer seasonal restocking and strong Zero Sugar demand partially offset sticky freight and resin costs. |
| Q3 2027 | 87.56 | +1.06% | -0.78% | Peak summer beverage demand across North America and rapid unit volume expansion across India drive quarterly revenue outperformance. Concentrate pricing adjustments protect gross margins, sparking modest defensive accumulation. |
| Q4 2027 | 88.77 | +1.38% | +0.59% | Judicial indications pointing toward a potential remand in the IRS tax dispute ease catastrophic balance-sheet concerns. Robust holiday off-premise beverage consumption and solid cash conversion support moderate year-end equity appreciation. |
| Q1 2028 | 89.41 | +0.72% | +1.32% | Annual packaging architecture optimizations successfully absorb localized supply-chain inflation. Management reaffirms mid-single-digit organic guidance alongside another dividend boost, preserving core institutional backing despite elevated risk-free yields. |
| Q2 2028 | 90.92 | +1.69% | +3.03% | Global sporting event marketing campaigns accelerate international case volume velocity across Latin America and Europe. Scaled concentrate shipments generate positive operating leverage, lifting quarterly operating profit above consensus projections. |
| Q3 2028 | 91.74 | +0.90% | +3.95% | Premium hydration platforms, including fairlife and smartwater, expand consolidated realization per gallon. Strong international volume gains counterbalance mature-market affordability fatigue, sustaining steady through-cycle operating earnings compounding. |
| Q4 2028 | 92.40 | +0.72% | +4.70% | Resolution of pending tax contingencies liberates corporate capital allocation, enabling steady programmatic share repurchases. Refranchised bottling efficiencies maximize free cash flow conversion, delivering modest per-share capital appreciation. |
| Q1 2029 | 93.38 | +1.06% | +5.81% | Full-year earnings confirm consistent single-digit operating profit expansion and another consecutive annual dividend increase. Reliable free cash generation defends equity valuation against persistent high-rate fixed-income competition. |
| Q2 2029 | 94.78 | +1.51% | +7.40% | Accelerated distribution penetration in emerging Asian markets and ready-to-drink alcohol collaborations unlock high-margin royalty streams. Expanding international concentrate throughput powers a solid mid-year operating earnings upside beat. |
| Q3 2029 | 95.98 | +1.26% | +8.76% | Gradual global monetary easing reduces discount-rate hurdles for premier defensive compounders. Peak warm-weather volume throughput and favorable commodity hedging programs protect corporate operating margins near twenty-nine percent. |
| Q4 2029 | 96.77 | +0.82% | +9.65% | Institutional portfolio rebalancing rewards dependable free cash generators as broader macro growth cools. Consistent consumer checkout frequency and disciplined overhead control drive measured fourth-quarter share price appreciation. |
| Q1 2030 | 97.47 | +0.72% | +10.45% | Annual financial reporting showcases structural return on invested capital exceeding thirty percent. Continued revenue growth management offsets minor raw material inflation, underpinning orderly valuation gains alongside dividend compounding. |
| Q2 2030 | 99.20 | +1.78% | +12.41% | Accelerated commercial beverage conversion across urbanizing developing territories fuels strong international volume growth. Automated route-to-market systems improve distributor fulfillment, driving quarterly operating earnings growth above consensus models. |
| Q3 2030 | 100.20 | +1.01% | +13.54% | Stable packaging input costs and sustained consumer brand inelasticity protect conversion spreads across international bottling networks. Balanced pricing and volume contributions maintain steady price consolidation around fair value. |
| Q4 2030 | 101.14 | +0.94% | +14.61% | Dependable holiday beverage consumption and robust commercial fountain shipments generate strong annual operating cash flow. Ongoing anti-dilutive share repurchases absorb secondary market float, securing incremental year-end price progress. |
| Q1 2031 | 102.38 | +1.23% | +16.02% | Management marks another consecutive annual dividend milestone while maintaining mid-single-digit organic guidance. Pristine asset-light royalty streams insulate bottom-line cash generation, supporting steady low-volatility equity compounding. |
| Q2 2031 | 103.48 | +1.07% | +17.26% | Scaled functional nutrition and premium dairy lines expand category diversification. Unrivaled direct-store-delivery logistics protect shelf space, driving solid second-quarter earnings outperformance across mature and emerging channels. |
| Q3 2031 | 104.37 | +0.85% | +18.26% | Five-year operational compounding culminates with normalized valuation multiples settling near twenty-two times earnings. Compounded per-share earnings growth overcomes macro discount-rate drag, concluding an orderly shareholder value creation cycle. |
Coca-Cola operates an unrivaled economic tollbooth, extracting high-margin syrup royalties while delegating capital-intensive bottling infrastructure to independent franchise partners. This asset-light architecture generates sustainable operating margins near 29% and over $14 billion in trailing free cash flow. Core organic compounding remains durable, supported by double-digit volume expansion in Zero Sugar, value-added dairy scaling through fairlife, and secular commercialization runways across developing markets. However, the equity's current valuation at 26.6 times trailing earnings clashes directly with a higher-for-longer macro regime where benchmark Treasuries yield 5.0%. Paying a negative equity risk premium for mid-single-digit organic growth guarantees that valuation multiple compression toward 21-23 times will neutralize roughly half of fundamental operating profit growth over the five-year forecast horizon.
Key insights
- Multiple compression from 26.6x toward 22x absorbs approximately three years of fundamental operating income growth amid 5% benchmark sovereign yields.
- The Eleventh Circuit transfer-pricing appeal represents an asymmetric contingency, holding $6 billion in deposited cash while risking $14 billion in unreserved liabilities.
- Refranchising deconsolidation shifts packaging inflation and fleet capex downstream, insulating parent return on invested capital above 30% despite mature-market consumer pushback.
Coca-Cola is an exceptional business whose stock price already reflects its operational success. By focusing on selling beverage concentrates and letting independent bottlers manage factories and delivery fleets, the company earns outstanding profits and reliable cash flow. Popular products like Coca-Cola Zero Sugar and fairlife milk continue driving steady sales growth worldwide. However, because the stock trades at an expensive valuation while government bonds pay high interest, future investment gains will be modest as the share price adjusts to reality.
Key insights
- High bond interest rates make expensive defensive stocks less attractive, pulling the company's valuation multiple down.
- An unresolved government tax lawsuit creates a multi-billion-dollar risk that restricts cash available for buying back stock.
- Focusing on high-margin syrups rather than expensive bottling plants keeps corporate profits strong during inflationary periods.
Deep Dive
Prevailing market consensus treats the company as an infallible defensive bond proxy, bidding shares near record valuations. The crowd assumes pricing power, unbroken dividend increases, and asset-light refranchising provide complete immunity against macroeconomic turbulence. Wall Street commentary projects perpetual mid-single-digit organic growth, largely dismissing five percent risk-free sovereign yields and treating the multi-billion-dollar federal transfer-pricing dispute as an inconsequential legal footnote.